Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis
AUTOR(ES)
Forbes, Raeburn B
FONTE
British Medical Journal
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=28295Documentos Relacionados
- Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
- Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
- Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a
- A case of cutaneous necrosis during interferon-beta 1b (B-IFN) therapy in multiple sclerosis.
- Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis